the Web site devoted to the study of the glucagon-like peptides
This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Samuel Lunenfeld Research Institute Banting and Best Diabetes Centre, University of Toronto
Acute GLP-1 receptor activation and postprandial lipemia in human subjects GLP-1 actions independent of glucose homeostasis
Evening vs morning suppression of DPP-4 activity with vildagliptin 100 mg once daily in human subjects with T2DM See Vildagliptin
Anti-inflammatory actions of exendin-4 in human islets See GLP-1 and the b-cell
GLP-1(9-36)amide directly suppreses hepatic glucose production See GLP-1 actions and a second GLP-1 receptor
